Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

A Prospective Study of Outcome After Therapy for Acromegaly

A legfontosabb adatok

Ki végzi
Columbia University
Hol
New York (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
280 fő vett részt
Kezdés
2003. szept.
Befejezés
2025. aug.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • Surgery for acromegaly
  • Medications for acromegaly
  • Total body magnetic resonance imaging
  • Adipose Tissue Biopsy
A regiszteradat frissítve
2025. augusztus 26.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 18 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult males and females
  • Ages 18 and over
  • Presenting to the PI or one of the sub-investigators for evaluation of acromegaly
  • Must have a biochemical diagnosis of acromegaly consisting of an elevated serum insulin-like growth factor 1 (IGF-1) level. Supportive although not required for entry are an elevated growth hormone (GH) level and a failure of GH to suppress normally after oral glucose administration
  • Willingness to participate in this study's procedures
  • Adult males and females
  • Ages 18 and over
  • Responding to ads for participation or by word of mount
  • No medical problems, no medications, stable weight for 3 months prior to study
  • Willingness to participate in this study's procedures

Ki nem vehet részt

  • Failure to meet the inclusion criteria
  • Subjects who are unwilling to comply with the procedures outlined in the study
  • Subjects who do not have the ability to fully comprehend the nature of the study, to follow instructions, and/or cooperate with study procedures
  • Are unwilling to provide informed consent to participate in the study; Healthy Subjects
  • Subjects who are unwilling to comply with the procedures outlined in the study
  • Subjects who do not have the ability to fully comprehend the nature of the study, to follow instructions, and/or cooperate with study procedures
  • Are unwilling to provide informed consent to participate in the study

Egyéb feltételek

  • Acromegaly Subjects

Helyszínek itt: Egyesült Államok

  • Neuroendocrine Unit; Columbia University Medical Center, 180 Fort Washington Avenue 9-970New York, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this study is to evaluate hormone values and other markers of disease activity in a cohort of patients with acromegaly at the time of diagnosis and then prospectively after surgical or other treatment. This study is designed to determine blood levels of growth hormone and related hormones and cardiovascular risk markers as well as signs and symptoms of the disease at diagnosis and how these parameters change over time after surgical or other therapy. The investigators will also obtain hormonal data in a group of 50 healthy subjects who will each be studied just once with an oral glucose tolerance test (OGTT). These data will provide a comparison group to the acromegaly subjects.

A vizsgálat 2 csoportja

  • Acromegaly Subjects

    People who have a biochemical diagnosis of acromegaly, and will or have already undergone surgery for acromegaly and will be taking medications for acromegaly . Subjects will undergo blood sampling, metabolic rate measurement, adipose tissue biopsy and total body magnetic resonance imaging before and over time after either surgery or medical therapy for acromegaly.

    Kezelés: Surgery for acromegaly, Medications for acromegaly, Total body magnetic resonance imaging és Adipose Tissue Biopsy

  • Healthy Subjects

    People who are not diagnosed with acromegaly, responding to flyer or by word of mouth for participation, without medical problems, not taking medications, and with a stable weight for 3 months prior to study. Subjects will undergo blood sampling, total body MRI and adipose tissue biopsy once.

    Kezelés: Total body magnetic resonance imaging és Adipose Tissue Biopsy

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Publikációk
A regiszteradat frissítve
2025. augusztus 26.